Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies

NCT01499147 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia
Acute Leukemia
Chronic Myelogenous Leukemia
Malignant Lymphoma
Hodgkin's Disease
Multiple Myeloma
Lymphocytic Leukemia
Myeloproliferative Disorder
Polycythemia Vera
Myelofibrosis
Aplastic Anemia

Interventions

DRUG: fludarabine/busulfan
DRUG: fludarabine/ melphalan
DRUG: ATG

Sponsor

University of Illinois at Chicago